190 related items for PubMed ID: 18618150
1. Prediction of high-degree steroid dependency in pediatric idiopathic nephrotic syndrome.
Letavernier B, Letavernier E, Leroy S, Baudet-Bonneville V, Bensman A, Ulinski T.
Pediatr Nephrol; 2008 Dec; 23(12):2221-6. PubMed ID: 18618150
[Abstract] [Full Text] [Related]
2. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
Aksu N, Türker M, Erdoğan H, Ozinel S, Kansoy S.
Turk J Pediatr; 1999 Dec; 41(2):225-30. PubMed ID: 10770662
[Abstract] [Full Text] [Related]
3. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
Hafeez F, Ahmad TM, Anwar S.
J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
[Abstract] [Full Text] [Related]
4. Remission of steroid- and CyA-resistant nephrotic syndrome using multiple drug immunosuppression.
Ulinski T, Perrin L, Guigonis V, Driss F, Deschênes G, Bensman A.
Pediatr Nephrol; 2007 Oct; 22(10):1723-6. PubMed ID: 17636340
[Abstract] [Full Text] [Related]
5. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J.
Pediatr Nephrol; 2005 Jul; 20(7):914-9. PubMed ID: 15891923
[Abstract] [Full Text] [Related]
6. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
Przegl Lek; 2006 Jul; 63 Suppl 3():44-8. PubMed ID: 16898486
[Abstract] [Full Text] [Related]
7. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Tenderenda E.
Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
[Abstract] [Full Text] [Related]
8. Long versus standard initial steroid therapy for children with the nephrotic syndromeA report from the Southwest Pediatric Nephrology Study Group.
Lande MB, Gullion C, Hogg RJ, Gauthier B, Shah B, Leonard MB, Bonilla-Felix M, Nash M, Roy S, Strife CF, Arbus G.
Pediatr Nephrol; 2003 Apr; 18(4):342-6. PubMed ID: 12700959
[Abstract] [Full Text] [Related]
9. [Childhood steroid-dependent idiopathic nephrotic syndrome: Predictive factors for the need of immunosuppressive treatment].
Golay M, Douillard A, Nagot N, Fila M, Ichay L, Dalla Vale F, Tenenbaum J, Morin D.
Arch Pediatr; 2017 Nov; 24(11):1096-1102. PubMed ID: 28941627
[Abstract] [Full Text] [Related]
10. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Hoyer PF, Brodeh J.
J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
[Abstract] [Full Text] [Related]
11. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults.
Tune BM, Mendoza SA.
J Am Soc Nephrol; 1997 May; 8(5):824-32. PubMed ID: 9176855
[Abstract] [Full Text] [Related]
12. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM, Wong SC, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2016 Oct 11; 10(10):CD003594. PubMed ID: 27726125
[Abstract] [Full Text] [Related]
13. Prediction of steroid-sparing agent use in childhood idiopathic nephrotic syndrome.
Harambat J, Godron A, Ernould S, Rigothier C, Llanas B, Leroy S.
Pediatr Nephrol; 2013 Apr 11; 28(4):631-8. PubMed ID: 23179197
[Abstract] [Full Text] [Related]
14. Long-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome.
Fujinaga S, Nishino T, Umeda C, Tomii Y, Watanabe Y, Sakuraya K.
Pediatr Nephrol; 2019 Feb 11; 34(2):353-357. PubMed ID: 30426219
[Abstract] [Full Text] [Related]
15. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Liu ID, Willis NS, Craig JC, Hodson EM.
Cochrane Database Syst Rev; 2019 Nov 21; 2019(11):. PubMed ID: 31749142
[Abstract] [Full Text] [Related]
16. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov 21; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
17. Cyclosporine in steroid dependent and resistant childhood nephrotic syndrome.
Iyengar A, Karthik S, Kumar A, Biswas S, Phadke K.
Indian Pediatr; 2006 Jan 21; 43(1):14-9. PubMed ID: 16465001
[Abstract] [Full Text] [Related]
18. Efficacy and Safety of Rituximab in Children With Steroid- and Cyclosporine-resistant and Steroid- and Cyclosporine-dependent Nephrotic Syndrome.
Hoseini R, Sabzian K, Otukesh H, Zafaranloo N, Panahi P, Rahimzadeh N, Nakhaie S, Akhavan Sepehi M.
Iran J Kidney Dis; 2018 Jan 21; 12(1):27-32. PubMed ID: 29421774
[Abstract] [Full Text] [Related]
19. Cyclosporine experience in nephrotic syndrome.
Phadke K, Ballal S, Maiya V.
Indian Pediatr; 1998 Feb 21; 35(2):111-6. PubMed ID: 9707852
[Abstract] [Full Text] [Related]
20. [Treatment of idiopathic nephrotic syndrome with cyclosporin A].
Ariceta Iraola G, Rodríguez Soriano J, Vallo Boado A, Quintela Pérez MJ, Oliveros Pérez R.
An Esp Pediatr; 1997 Sep 21; 47(3):273-8. PubMed ID: 9499280
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
